SCHEMBL3848151

SCHEMBL3848151

COc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncc(-c4noc(C5CC5)n4)n3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
GAA P10253 1/20 0.37
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
HTT P42858 1/20 0.36
MAPT P10636 3/20 0.36
CPT1A P50416 2/20 0.35
KIT P10721 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845896 0.91 TP53 (0.37) ALDH1A1KDM4EHPGDCASP1CASP7
SCHEMBL3847074 0.90 LMNA (0.38) ALDH1A1LMNATSHRHTTMAPT
SCHEMBL3848153 0.87 ALDH1A1 (0.33) ALDH1A1KDM4EHPGDCASP1CASP7
SCHEMBL3846554 0.86 CNR2 (0.39) GABRA1GABRA3LMNATSHRKIT
SCHEMBL3845566 0.85 HRH3 (0.38) KITPIK3CAPIK3CBMTORCDK19
SCHEMBL3845667 0.85 KIT (0.36) GABRA1GABRA3LMNATSHRHTT
SCHEMBL3847653 0.84 KIT (0.36) KITPIK3CAPIK3CBMTORCDK19
SCHEMBL3854699 0.84 MAPK14 (0.40) LMNATSHRHTTMAPTKIT
SCHEMBL3852720 0.83 KIT (0.35) ALDH1A1KDM4EHPGDCASP1CASP7
SCHEMBL3846800 0.82 CNR2 (0.39) KITPIK3CAPIK3CBMTORCDK19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed